Company intelligence / Profile preview

Jumpstart Fertility

Boston, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Jumpstart Fertility is a biotechnology company focused on developing small molecule therapies to restore egg quality and treat female infertility. The company's research is based on the work of Dr. David Sinclair and Dr. Lindsay Wu, specifically targeting the restoration of NAD+ levels to reverse the effects of reproductive aging. By boosting metabolic health within oocytes, Jumpstart aims to improve the success rates of natural conception and assisted reproductive technologies. The company was acquired by Life Biosciences and integrated into its platform of companies targeting age-related diseases.

Therapeutic areas: Women's Health
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Jumpstart Fertility.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jumpstart Fertility.

Explore the full profile